BridgeBio Oncology Therapeutics, Inc. BBOT
Regular-session close
After hours · Nov 20, 4:00 PM ET
- YTD
- -85.54%
- 1 year
- -85.14%
Held by funds
21 US ETFs and mutual funds hold BBOT · largest positions
- SHSSX 0.06% of fund $3.62M
- VTI 0.00% of fund $2.94M
- XBI 0.01% of fund $1.31M
- VXF 0.00% of fund $1.30M
- FSMAX 0.00% of fund $844.72K
- IBB 0.01% of fund $676.41K
- SCHA 0.00% of fund $444.30K
- VBINX 0.00% of fund $116.40K
- FZIPX 0.00% of fund $83.81K
- VITPX 0.00% of fund $75.44K
- FLXSX 0.01% of fund $63.86K
- BBC 0.19% of fund $62.18K
- SCHB 0.00% of fund $53.31K
- LABU 0.01% of fund $48.00K
- HKG 0.01% of fund $21.39K
- DFAS 0.00% of fund $8.20K
- DFSU 0.00% of fund $7.14K
- DCOR 0.00% of fund $5.61K
- DFMC 0.00% of fund $5.18K
- KBFR 0.03% of fund $4.31K
Ownership
- Institutions 52.9%
- Insiders 24.0%
- Public and other holders 23.1%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Alphabet Inc. | 3.56% | 2,823,126 | 34.95M | Sep 29, 2025 |
| Blackrock Inc. | 2.59% | 2,048,552 | 25.36M | Sep 29, 2025 |
| Vanguard Group Inc | 0.82% | 647,599 | 8.02M | Sep 29, 2025 |
| Aisling Capital Management LP | 0.71% | 564,625 | 6.99M | Sep 29, 2025 |
| Geode Capital Management, LLC | 0.68% | 541,602 | 6.71M | Sep 29, 2025 |
| SilverArc Capital Management, LLC | 0.58% | 457,414 | 5.66M | Sep 29, 2025 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| BlackRock Funds-BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO | 1.06% | 841,293 | 10.42M | Aug 30, 2025 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 0.32% | 251,285 | 3.11M | Sep 29, 2025 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 0.17% | 134,677 | 1.67M | Sep 29, 2025 |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 0.12% | 91,183 | 1.13M | Sep 29, 2025 |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 0.09% | 68,315 | 845.74K | Sep 29, 2025 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 0.06% | 48,351 | 598.59K | Sep 29, 2025 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs BBOT, and what each was last paid
Pedro J. Beltran, Chief Executive Officer and DirectorAverage age 51
| Name | Title | Pay | Age |
|---|---|---|---|
| Pedro J. Beltran | Chief Executive Officer and Director | $768K | 55 |
| Yong Ben | Chief Medical & Development Officer | $771K | 52 |
| Frank McCormick | Co-Founder, Non-Executive Director & Chair of the Advisory Board | $65.0K | 76 |
| Neil Kumar | Executive Chairman | $20.0K | 47 |
| Rui Xu | Senior Vice President of Drug Discovery | — | — |
| Daniel Watson | Senior Vice President of Chemistry, Manufacturing & Controls | — | — |
| Idan Elmelech | Chief Operating Officer | — | 33 |
| Marc Cobo | VP of Finance & Controller | — | 45 |
| Aaron Chan | Vice President of Legal | — | — |
| Bin Wang | Senior Vice President of Drug Discovery | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHEN BIHUA X. | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Aug 10, 2025 | 0 |
| HELIX HOLDINGS II L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Feb 12, 2024 | 0 |
| HOLMAN ALBERT A III | Former | Conversion of Exercise of derivative security | Aug 10, 2025 | 30,000 |
| MCKENNA MARK C | Former | Conversion of Exercise of derivative security | Aug 10, 2025 | 30,000 |
| SCHMID JOHN P | Former | Conversion of Exercise of derivative security | Aug 10, 2025 | 30,000 |
